Our following assays revealed that miR-373-3p silencing weakened the inhibiting activities of ASP on the TGF-β/Smad4 pathway in glioma cells, indicating a negative regulatory relationship between miR-373-3p and the TGF-β/Smad4 pathway. The gene discussed is SMAD4; the disease is central nervous system cancer.